Tevis Investment Management Amgen Inc Transaction History

Tevis Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $13,243 - $14,935	59 Added 19.54%	361 $81,000
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $5,998 - $6,675	26 Added 9.42%	302 $72,000
Q1 2022 Aug 05, 2022	BUY	$219.27 - $242.57 $22,146 - $24,499	101 Added 57.71%	276 $66,000
Q4 2021 Aug 05, 2022	BUY	$198.88 - $227.6 $34,804 - $39,830	175 New	175 $39,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Tevis Investment Management, based on Form 13F filings with the SEC.

Stay updated on Tevis Investment Management with notifications on news.